Gil Labrucherie

Gil Labrucherie, CFO at Nektar Therapeutics (NASDAQ:NKTR), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Labrucherie sold 24,149 shares of Nektar Therapeutics at...